Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
128.50
-0.88 (-0.68%)
At close: Jun 30, 2026, 4:00 PM EDT
128.00
-0.50 (-0.39%)
After-hours: Jun 30, 2026, 7:57 PM EDT

Merck & Co. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Net Income
-4,2432,9625,7874,4295,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2523,9494,3073,8244,5711,214
Depreciation & Amortization
1,5122,4661,1541,1191,0991,1971,1861,1329849641,0149039918929599381,120835759728
Stock-Based Compensation
185205204216195187195203176167164169145145139137120119117132
Other Adjustments
8,077-512-637-212-1678381,467-147545-595-4015,13226872279677513362-511601
Changes in Other Operating Activities
-1,613-1,314-2,259-3,712-2,582-1,012-3,382-2,177-1,636-2,890-263-1,399-1,299-64-139-963
Operating Cash Flow
3,9182,8577,8223,2932,5003,4509,2915,6373,0902467,7173,7041,3394,4305,6024,3024,7615,0314,7972,490
Operating Cash Flow Growth
56.72%-17.19%-15.81%-41.58%-19.09%1302.44%20.40%52.19%130.77%-94.45%37.75%-13.90%-71.88%-11.95%16.78%72.77%165.83%744.13%120.75%22.24%
Capital Expenditures
-991-1,033-987-764-1,328-937-783-791-861-989-902-965-1,007-1,149-1,126-1,129-984-1,208-1,172-986
Purchases of Investments
-37400-612-595-4550-49-15-151-117-25-562-494-5-333-372000
Proceeds from Sale of Investments
-46575601456750602601697042855001233537315291110
Payments for Business Acquisitions
-8,779-----200-74600-5,353-1,327-----901-822
Other Investing Activities
-66-1721295-20-57233-289-14-21-19-3337-117-4512182-106-1-77
Investing Cash Flow
-10,210-11,201-283-770-1,487-1,444-3,845-1,069-1,37653-334-11,443-2,359-1,748-962-1,077-1,173-12,049-1,061-2,707
Long-Term Debt Issued
-7,9185,962--0-11,800-0-72,973--------
Long-Term Debt Repaid
-1,140-2-10-2,500-53900-751-3-1-1,750-1-1-1,0000-1,250-2,83300
Net Long-Term Debt Issued (Repaid)
-1,1407,9165,9610-2,500-539-11,800-751-3-81,223-1-1-1,0000-1,250-2,83300
Issuance of Common Stock
1574714121912573876782302651097121341742
Repurchase of Common Stock
-874-1,252-1,323-1,345-1,164-489-444-251-122-393-466-338-149-----18-583-119.5
Net Common Stock Issued (Repurchased)
-717-1,205-1,309-1,333-1,145-477-439-178-35-387-459-256-119265109712116-566-77.5
Common Dividends Paid
-2,105-2,018-2,031-2,077-2,050-1,951-1,953-1,986-1,950-1,852-1,855-1,885-1,853-1,750-1,747-1,770-1,745-1,643-1,649-1,673
Other Financing Activities
-1,124-1,897-2,014-2,223-2,110-1,993-1,985-2,206-2,028-1,855-1,865-1,151-1,934-1,818-1,712-1,874-1,848-1,679-1,708-2,293
Financing Cash Flow
-2,9814,7512,638-3,556-5,755-3,009-2,4251,216-2,814-2,245-4,2693,758-2,054-1,554-2,702-1,777-3,0865,207-2,2742,010
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-192310374156-367294-82-138186-157-9387366-412-309-55-68-4678
Net Cash Flow
-9,292-3,57010,187-659-4,586-1,3703,3155,702-1,238-1,7602,957-4,074-2,9871,4941,5261,139447-1,8791,4161,619
Free Cash Flow
2,9271,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,8233,6251,504
Free Cash Flow Growth
149.74%-27.42%-19.66%-47.81%-47.42%-24.84%76.93%571.39%-52.26%-13.68%-91.21%-14.18%23.48%110.97%432.72%-397.94%9.86%
FCF Margin
17.97%11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%27.56%13.19%
Free Cash Flow Per Share
1.180.732.741.010.460.993.351.900.88-0.292.681.080.131.291.761.251.491.511.430.59
Levered Free Cash Flow
-6,47212,31213,2272,523-1,3623,4646,1416,584752-1,2547,026-6,450-862,7592,3442,3541,8974884,015324
Unlevered Free Cash Flow
-5,1694,7697,0642,5181,1144,1186,0214,8281,480-1,2047,145-7,477-12.122,6973,7382,7443,7713,0603,628-79.83
SEC Filings: 10-K · 10-Q